Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jill Ann Howe Insider Profile
4 Followers
Jill Ann Howe, Director at Biora Therapeutics, holds 25.50K shares in Lineage Therap (Ticker: LCTX), holds 31.92K shares in Biora Therapeutics (Ticker: BIOR). Most recently, Jill Ann Howe Bought ― shares of Lineage Therap on Nov 26, 2024 for an estimated value of 8.85K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-18.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jill Ann Howe holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jill Ann Howe
Jill Ann Howe's Trading History
Biora Therapeutics
Jun 06, 2024
Director
Uninformative Buy
―
$19.15K
Lineage Therap
Nov 26, 2024
CFO
Informative Buy
8.85K
$14.23K
List of latest transactions for each holding click on a transaction to see Jill Ann Howe's performance on stock
You May Also Like
Jill Ann Howe insider profile FAQ
What is the percentage of profitable transactions made by Jill Ann Howe?
The percentage of profitable transactions made by Jill Ann Howe is 0%.
What is the average return per transaction made by Jill Ann Howe?
The average return per transaction made by Jill Ann Howe is -18.40%.
What stocks does Jill Ann Howe hold?
Jill Ann Howe holds: BIOR, LCTX stocks.
What was Jill Ann Howe’s latest transaction?
Jill Ann Howe latest transaction was an Informative Buy of $8.85K.
What was Jill Ann Howe's most profitable transaction?
Jill Ann Howe’s most profitable transaction was an Informative Buy of LCTX stock on November 26, 2024. The return on the trade was -3.30%.
What is Jill Ann Howe's role in Biora Therapeutics?
Jill Ann Howe's role in Biora Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.